RLMD – relmada therapeutics, inc. (US:AMEX)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

RLMD

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/23

08:04 am

rlmd

Relmada Therapeutics (NASDAQ:RLMD) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $8.00 price target on the stock.

Medium Report

Relmada Therapeutics (NASDAQ:RLMD) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $8.00 price target on the stock.

Report

1/23

07:04 am

rlmd

Rating for RLMD

Medium Report

Rating for RLMD

Report

12/22

07:18 am

rlmd

Rating for RLMD

Low Report

Rating for RLMD

Report

12/22

07:18 am

rlmd

Rating for RLMD

Low Report

Rating for RLMD

Report

12/21

07:08 pm

rlmd

Relmada Therapeutics initiated with a Buy at Jefferies

Medium Report

Relmada Therapeutics initiated with a Buy at Jefferies

Report

12/21

07:08 pm

rlmd

Relmada Therapeutics initiated with a Buy at Jefferies

Medium Report

Relmada Therapeutics initiated with a Buy at Jefferies

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.